搜尋





搜尋





Celldex Therapeutics Inc

CLDX

添加自選

37.810USD

-1.170-3.00%

交易中 09/18, 14:33（美東）

2.97B總市值

虧損本益比TTM

Celldex Therapeutics Inc

37.810

-1.170-3.00%

財務摘要利潤表資產負債表現金流量表財報公司估值風險評估

概覽

財務

股票評分

技術分析

預測

持股情況

股息

公司資料

財務摘要利潤表資產負債表現金流量表財報公司估值風險評估

CLDX 利潤表

您可以在這裡找到Celldex Therapeutics Inc的年度或季度收入報告，以深入了解Celldex Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

FY2016Q2

FY2016Q1

FY2015Q4

FY2015Q3

FY2015Q2

FY2015Q1

FY2014Q4

FY2014Q3

FY2014Q2

FY2014Q1

FY2013Q4

FY2013Q3

FY2013Q2

FY2013Q1

FY2012Q4

FY2012Q3

FY2012Q2

FY2012Q1

營業總收入

-96.99%22.00K

-97.84%15.00K

-89.70%121.00K

-100.00%0.00

-70.78%730.00K

345.51%695.00K

-71.56%1.18M

110.35%3.19M

832.09%2.50M

-83.87%156.00K

156.11%4.13M

272.73%1.52M

64.42%268.00K

455.75%967.00K

382.93%1.61M

166.01%407.00K

-95.32%163.00K

-74.60%174.00K

-91.18%334.00K

-77.10%153.00K

1374.58%3.48M

-74.89%685.00K

326.72%3.79M

22.34%668.00K

-66.99%236.00K

91.44%2.73M

-49.72%887.00K

-41.98%546.00K

-74.12%715.00K

-64.97%1.43M

-48.96%1.76M

-76.02%941.00K

-27.84%2.76M

165.19%4.07M

84.52%3.46M

76.76%3.92M

175.67%3.83M

17.73%1.53M

4.58%1.87M

116.37%2.22M

-36.23%1.39M

168.11%1.30M

21.26%1.79M

-6.81%1.03M

267.91%2.18M

16.83%486.00K

138.23%1.48M

12.35%1.10M

510.31%592.00K

-82.77%416.00K

-83.00%620.00K

-68.52%980.00K

-95.17%97.00K

-0.78%2.41M

--3.65M

--3.11M

--2.01M

--2.43M

營業收入

-96.99%22.00K

-97.84%15.00K

-89.70%121.00K

-100.00%0.00

-70.78%730.00K

345.51%695.00K

-71.56%1.18M

110.35%3.19M

832.09%2.50M

-83.87%156.00K

156.11%4.13M

272.73%1.52M

64.42%268.00K

455.75%967.00K

382.93%1.61M

166.01%407.00K

-95.32%163.00K

-74.60%174.00K

-91.18%334.00K

-77.10%153.00K

1374.58%3.48M

-74.89%685.00K

326.72%3.79M

22.34%668.00K

-66.99%236.00K

91.44%2.73M

-49.72%887.00K

-41.98%546.00K

-74.12%715.00K

-64.97%1.43M

-48.96%1.76M

-76.02%941.00K

-27.84%2.76M

165.19%4.07M

84.52%3.46M

76.76%3.92M

175.67%3.83M

17.73%1.53M

4.58%1.87M

116.37%2.22M

-36.23%1.39M

168.11%1.30M

21.26%1.79M

-6.81%1.03M

267.91%2.18M

16.83%486.00K

138.23%1.48M

12.35%1.10M

510.31%592.00K

-82.77%416.00K

-83.00%620.00K

-68.52%980.00K

-95.17%97.00K

-0.78%2.41M

--3.65M

--3.11M

--2.01M

--2.43M

主營業務成本

----

0.00%254.00K

-90.22%253.00K

-93.35%253.00K

-92.21%254.00K

-88.26%254.00K

-1.82%2.59M

--3.81M

--3.26M

--2.16M

--2.63M

營業費用

24.86%80.64M

33.13%84.45M

52.57%87.27M

33.08%73.62M

32.31%64.59M

55.61%63.43M

45.71%57.20M

29.38%55.32M

45.83%48.81M

21.91%40.76M

33.09%39.26M

52.14%42.76M

20.04%33.47M

39.52%33.44M

41.01%29.50M

45.03%28.10M

67.36%27.89M

42.31%23.97M

48.91%20.92M

35.06%19.38M

25.91%16.66M

9.63%16.84M

3.61%14.05M

-1.08%14.35M

-5.40%13.23M

-4.27%15.36M

-12.75%13.56M

-7.26%14.50M

-48.32%13.99M

-42.05%16.05M

-47.47%15.54M

-43.10%15.64M

-14.76%27.07M

-16.71%27.69M

-19.45%29.58M

-14.68%27.48M

-5.92%31.76M

-10.16%33.25M

4.25%36.73M

-3.55%32.21M

-3.36%33.76M

17.61%37.01M

5.07%35.23M

6.21%33.40M

19.86%34.93M

-1.37%31.47M

47.48%33.53M

29.67%31.44M

55.38%29.14M

61.01%31.91M

12.56%22.73M

35.74%24.25M

21.02%18.75M

26.04%19.82M

--20.20M

--17.86M

--15.50M

--15.72M

研發費用

24.63%67.54M

38.75%73.00M

60.49%75.33M

39.03%62.93M

36.56%54.20M

66.18%52.61M

54.27%46.94M

31.06%45.26M

51.18%39.69M

18.15%31.66M

32.87%30.43M

60.09%34.53M

26.63%26.25M

57.12%26.80M

56.01%22.90M

59.12%21.57M

67.78%20.73M

34.09%17.06M

40.80%14.68M

26.61%13.56M

27.32%12.36M

8.76%12.72M

0.83%10.43M

-3.54%10.71M

-3.73%9.71M

4.88%11.70M

-7.75%10.34M

-6.86%11.10M

-53.00%10.08M

-49.02%11.15M

-52.24%11.21M

-45.62%11.92M

-14.20%21.45M

-15.19%21.88M

-4.45%23.46M

-12.37%21.91M

-2.77%25.00M

-6.03%25.79M

2.75%24.56M

1.43%25.01M

-2.94%25.71M

9.24%27.45M

-11.57%23.90M

-5.84%24.66M

9.92%26.49M

-7.19%25.13M

51.80%27.03M

28.25%26.18M

59.71%24.10M

92.12%27.07M

29.52%17.80M

73.48%20.42M

35.77%15.09M

30.84%14.09M

--13.75M

--11.77M

--11.11M

--10.77M

折舊攤銷及損耗

3.32%902.00K

-1.50%854.00K

-0.37%816.00K

4.83%824.00K

9.54%873.00K

11.87%867.00K

7.91%819.00K

2.48%786.00K

5.42%797.00K

6.75%775.00K

12.78%759.00K

14.31%767.00K

2.02%756.00K

-10.48%726.00K

-13.38%673.00K

-10.77%671.00K

-3.01%741.00K

4.65%811.00K

2.91%777.00K

-12.66%752.00K

-33.45%764.00K

-33.48%775.00K

-34.06%755.00K

-28.73%861.00K

-0.43%1.15M

-13.83%1.17M

58.81%1.15M

44.67%1.21M

16.11%1.15M

7.99%1.35M

-42.13%721.00K

-33.15%835.00K

-18.94%993.00K

-21.26%1.25M

4.09%1.25M

30.79%1.25M

29.49%1.23M

59.80%1.59M

8.82%1.20M

-6.46%955.00K

-2.07%946.00K

7.57%995.00K

25.43%1.10M

19.14%1.02M

15.55%966.00K

59.76%925.00K

14.94%877.00K

16.92%857.00K

14.68%836.00K

-19.69%579.00K

5.24%763.00K

-3.17%733.00K

-11.21%729.00K

-13.65%721.00K

--725.00K

--757.00K

--821.00K

--835.00K

營業利潤

-26.26%-80.62M

-34.58%-84.44M

-55.56%-87.15M

-41.23%-73.62M

-37.87%-63.86M

-54.50%-62.74M

-59.50%-56.03M

-26.40%-52.13M

-39.49%-46.32M

-25.06%-40.61M

-25.97%-35.13M

-48.90%-41.24M

-19.78%-33.20M

-36.47%-32.47M

-35.46%-27.89M

-44.06%-27.70M

-110.30%-27.72M

-47.27%-23.79M

-100.57%-20.59M

-40.53%-19.23M

-1.42%-13.18M

-27.89%-16.16M

19.00%-10.26M

1.99%-13.68M

2.09%-13.00M

13.60%-12.63M

8.02%-12.67M

5.04%-13.96M

45.39%-13.27M

38.11%-14.62M

47.27%-13.78M

37.61%-14.70M

12.97%-24.31M

25.50%-23.62M

25.04%-26.13M

21.45%-23.56M

13.71%-27.93M

11.18%-31.71M

-4.23%-34.85M

7.35%-29.99M

1.17%-32.37M

-15.24%-35.70M

-4.33%-33.44M

-6.69%-32.37M

-14.72%-32.75M

1.61%-30.98M

-44.94%-32.05M

-30.40%-30.34M

-53.01%-28.55M

-80.96%-31.49M

-33.62%-22.11M

-57.75%-23.27M

-38.33%-18.66M

-30.95%-17.40M

---16.55M

---14.75M

---13.49M

---13.29M

淨非營業利息收入（費用）

利息費用

----

-100.00%0.00

-75.78%85.00K

-96.59%13.00K

26.28%519.00K

-28.41%310.00K

--351.00K

--381.00K

--411.00K

--433.00K

出售證券收益

-1.89%7.12M

-35.70%5.75M

-34.68%5.84M

-34.30%6.57M

-30.72%7.26M

14.65%8.94M

106.78%8.94M

235.85%10.01M

287.53%10.47M

150.80%7.80M

209.08%4.32M

226.64%2.98M

589.54%2.70M

1402.42%3.11M

628.13%1.40M

528.97%912.00K

485.07%392.00K

104.95%207.00K

-90.11%192.00K

22.88%145.00K

-36.79%67.00K

-58.26%101.00K

-23.60%1.94M

-72.62%118.00K

-77.82%106.00K

-65.53%242.00K

-6.54%2.54M

-17.27%431.00K

2.58%478.00K

-10.00%702.00K

4.49%2.72M

30.90%521.00K

28.73%466.00K

-8.34%780.00K

2.28%2.60M

0.76%398.00K

-12.56%362.00K

-17.46%851.00K

237.53%2.54M

1.02%395.00K

5.88%414.00K

27.76%1.03M

229.26%754.00K

-82.70%391.00K

42.18%391.00K

-49.12%807.00K

67.15%229.00K

1491.55%2.26M

70.81%275.00K

318.47%1.59M

45.74%137.00K

35.24%142.00K

27.78%161.00K

84.88%379.00K

--94.00K

--105.00K

--126.00K

--205.00K

特殊收入（費用）

----

100.00%0.00

----

---12.50M

--0.00

100.00%0.00

-100.00%0.00

100.00%0.00

-3262.02%-8.67M

210.97%536.00K

101.69%245.00K

-141.54%-1.60M

-115.81%-258.00K

-106.41%-483.00K

-4465.41%-14.52M

-131.32%-662.00K

60.47%1.63M

92.95%-234.00K

-119.24%-318.00K

-69.52%2.11M

-86.32%1.02M

96.54%-3.32M

175.50%1.65M

182.56%6.94M

843.30%7.43M

-2725.09%-96.05M

--600.00K

---8.40M

---1.00M

---3.40M

----

其他非經營性收入（費用）

----

--0.23

----

稅前利潤

-29.86%-73.50M

-46.27%-78.69M

-72.68%-81.32M

-59.17%-67.04M

-57.92%-56.60M

-63.97%-53.80M

-8.74%-47.09M

-10.09%-42.12M

-17.51%-35.84M

-11.74%-32.81M

-63.50%-43.31M

-42.85%-38.26M

15.28%-30.50M

-27.38%-29.36M

-31.46%-26.49M

-29.52%-26.78M

-169.23%-36.00M

-39.38%-23.05M

11.78%-20.15M

-45.38%-20.68M

-18.78%-13.37M

-30.99%-16.54M

-118.62%-22.84M

-24.63%-14.22M

4.41%-11.26M

26.76%-12.63M

-11.10%-10.45M

-57.57%-11.41M

28.21%-11.78M

85.50%-17.24M

58.98%-9.40M

77.05%-7.24M

42.56%-16.41M

-247.03%-118.90M

29.05%-22.92M

-6.64%-31.56M

10.60%-28.57M

1.19%-34.26M

1.15%-32.31M

7.45%-29.60M

1.26%-31.95M

-14.91%-34.67M

-2.71%-32.68M

-13.88%-31.98M

-14.45%-32.36M

-0.91%-30.17M

-44.24%-31.82M

-21.36%-28.08M

-48.69%-28.27M

-72.53%-29.90M

-31.27%-22.06M

-53.99%-23.14M

-38.07%-19.02M

-28.23%-17.33M

---16.81M

---15.03M

---13.77M

---13.52M

所得稅

----

--0.00

----

--0.00

----

--0.00

100.00%0.00

----

100.00%0.00

---227.00K

100.00%0.00

----

---939.00K

--0.00

---228.00K

----

--0.00

100.00%0.00

-100.00%0.00

100.00%0.00

--0.00

---765.00K

--18.00K

---5.20M

----

--0.00

除稅後利潤

-29.86%-73.50M

-46.27%-78.69M

-72.68%-81.32M

-59.17%-67.04M

-57.92%-56.60M

-63.97%-53.80M

-8.74%-47.09M

-10.09%-42.12M

-17.51%-35.84M

-11.74%-32.81M

-63.50%-43.31M

-42.85%-38.26M

15.28%-30.50M

-27.38%-29.36M

-31.46%-26.49M

-30.96%-26.78M

-169.23%-36.00M

-39.38%-23.05M

8.00%-20.15M

-43.79%-20.45M

-21.23%-13.37M

-30.99%-16.54M

-109.63%-21.90M

-24.63%-14.22M

6.35%-11.03M

26.76%-12.63M

-11.10%-10.45M

-57.57%-11.41M

28.21%-11.78M

85.41%-17.24M

59.01%-9.40M

72.53%-7.24M

42.56%-16.41M

-244.80%-118.13M

28.99%-22.94M

10.93%-26.36M

10.60%-28.57M

1.19%-34.26M

1.15%-32.31M

7.45%-29.60M

1.26%-31.95M

-14.91%-34.67M

-2.71%-32.68M

-13.88%-31.98M

-14.45%-32.36M

-0.91%-30.17M

-44.24%-31.82M

-21.36%-28.08M

-48.69%-28.27M

-72.53%-29.90M

-31.27%-22.06M

-53.99%-23.14M

-38.07%-19.02M

-28.23%-17.33M

---16.81M

---15.03M

---13.77M

---13.52M

持續經營利潤

-29.86%-73.50M

-46.27%-78.69M

-72.68%-81.32M

-59.17%-67.04M

-57.92%-56.60M

-63.97%-53.80M

-8.74%-47.09M

-10.09%-42.12M

-17.51%-35.84M

-11.74%-32.81M

-63.50%-43.31M

-42.85%-38.26M

15.28%-30.50M

-27.38%-29.36M

-31.46%-26.49M

-30.96%-26.78M

-169.23%-36.00M

-39.38%-23.05M

8.00%-20.15M

-43.79%-20.45M

-21.23%-13.37M

-30.99%-16.54M

-109.63%-21.90M

-24.63%-14.22M

6.35%-11.03M

26.76%-12.63M

-11.10%-10.45M

-57.57%-11.41M

28.21%-11.78M

85.41%-17.24M

59.01%-9.40M

72.53%-7.24M

42.56%-16.41M

-244.80%-118.13M

28.99%-22.94M

10.93%-26.36M

10.60%-28.57M

1.19%-34.26M

1.15%-32.31M

7.45%-29.60M

1.26%-31.95M

-14.91%-34.67M

-2.71%-32.68M

-13.88%-31.98M

-14.45%-32.36M

-0.91%-30.17M

-44.24%-31.82M

-21.36%-28.08M

-48.69%-28.27M

-72.53%-29.90M

-31.27%-22.06M

-53.99%-23.14M

-38.07%-19.02M

-28.23%-17.33M

---16.81M

---15.03M

---13.77M

---13.52M

反常淨利潤

----

--19.10M

----

歸属于母公司的淨利潤

-29.86%-73.50M

-46.27%-78.69M

-72.68%-81.32M

-59.17%-67.04M

-57.92%-56.60M

-63.97%-53.80M

-8.74%-47.09M

-10.09%-42.12M

-17.51%-35.84M

-11.74%-32.81M

-63.50%-43.31M

-42.85%-38.26M

15.28%-30.50M

-27.38%-29.36M

-31.46%-26.49M

-30.96%-26.78M

-169.23%-36.00M

-39.38%-23.05M

8.00%-20.15M

-43.79%-20.45M

-21.23%-13.37M

-30.99%-16.54M

-109.63%-21.90M

-24.63%-14.22M

6.35%-11.03M

26.76%-12.63M

-11.10%-10.45M

-57.57%-11.41M

28.21%-11.78M

85.41%-17.24M

-144.81%-9.40M

72.53%-7.24M

42.56%-16.41M

-244.80%-118.13M

88.11%-3.84M

10.93%-26.36M

10.60%-28.57M

1.19%-34.26M

1.15%-32.31M

7.45%-29.60M

1.26%-31.95M

-14.91%-34.67M

-2.71%-32.68M

-13.88%-31.98M

-14.45%-32.36M

-0.91%-30.17M

-44.24%-31.82M

-21.36%-28.08M

-48.69%-28.27M

-72.53%-29.90M

-31.27%-22.06M

-53.99%-23.14M

-38.07%-19.02M

-28.23%-17.33M

---16.81M

---15.03M

---13.77M

---13.52M

歸屬普通股東的淨利潤

-29.86%-73.50M

-46.27%-78.69M

-72.68%-81.32M

-59.17%-67.04M

-57.92%-56.60M

-63.97%-53.80M

-8.74%-47.09M

-10.09%-42.12M

-17.51%-35.84M

-11.74%-32.81M

-63.50%-43.31M

-42.85%-38.26M

15.28%-30.50M

-27.38%-29.36M

-31.46%-26.49M

-30.96%-26.78M

-169.23%-36.00M

-39.38%-23.05M

8.00%-20.15M

-43.79%-20.45M

-21.23%-13.37M

-30.99%-16.54M

-109.63%-21.90M

-24.63%-14.22M

6.35%-11.03M

26.76%-12.63M

-11.10%-10.45M

-57.57%-11.41M

28.21%-11.78M

85.41%-17.24M

-144.81%-9.40M

72.53%-7.24M

42.56%-16.41M

-244.80%-118.13M

88.11%-3.84M

10.93%-26.36M

10.60%-28.57M

1.19%-34.26M

1.15%-32.31M

7.45%-29.60M

1.26%-31.95M

-14.91%-34.67M

-2.71%-32.68M

-13.88%-31.98M

-14.45%-32.36M

-0.91%-30.17M

-44.24%-31.82M

-21.36%-28.08M

-48.69%-28.27M

-72.53%-29.90M

-31.27%-22.06M

-53.99%-23.14M

-38.07%-19.02M

-28.23%-17.33M

---16.81M

---15.03M

---13.77M

---13.52M

基本每股收益

-10.76%-0.94

-45.86%-1.18

-72.36%-1.22

-58.87%-1.01

-57.03%-0.85

-45.42%-0.81

14.69%-0.71

21.52%-0.64

15.89%-0.54

10.38%-0.56

-48.01%-0.83

-41.80%-0.81

16.17%-0.65

-26.10%-0.62

-30.35%-0.56

-26.88%-0.57

-128.10%-0.77

-18.13%-0.49

21.94%-0.43

-24.25%-0.45

32.43%-0.34

42.44%-0.42

12.95%-0.55

51.51%-0.36

40.83%-0.50

48.26%-0.73

21.45%-0.63

-12.52%-0.75

49.43%-0.84

88.88%-1.40

-91.50%-0.81

78.24%-0.66

51.22%-1.67

-200.89%-12.61

90.61%-0.42

30.83%-3.05

29.44%-3.42

20.49%-4.19

9.64%-4.49

9.39%-4.41

1.59%-4.85

-7.63%-5.27

6.76%-4.97

-3.30%-4.87

-3.85%-4.93

2.55%-4.90

-33.81%-5.33

-9.97%-4.71

-34.60%-4.75

-43.07%-5.02

1.24%-3.98

-13.04%-4.28

-0.24%-3.53

13.14%-3.51

---4.03

---3.79

---3.52

---4.04

稀釋每股收益

-10.76%-0.94

-45.86%-1.18

-72.36%-1.22

-58.87%-1.01

-57.03%-0.85

-45.42%-0.81

14.69%-0.71

21.52%-0.64

15.89%-0.54

10.38%-0.56

-48.01%-0.83

-41.80%-0.81

16.17%-0.65

-26.10%-0.62

-30.35%-0.56

-26.88%-0.57

-128.10%-0.77

-18.13%-0.49

21.94%-0.43

-24.25%-0.45

32.43%-0.34

42.44%-0.42

12.95%-0.55

51.51%-0.36

40.83%-0.50

48.26%-0.73

21.45%-0.63

-12.52%-0.75

49.43%-0.84

88.88%-1.40

-91.50%-0.81

78.24%-0.66

51.22%-1.67

-200.89%-12.61

90.61%-0.42

30.83%-3.05

29.44%-3.42

20.49%-4.19

9.64%-4.49

9.39%-4.41

1.59%-4.85

-7.63%-5.27

6.76%-4.97

-3.30%-4.87

-3.85%-4.93

2.55%-4.90

-33.81%-5.33

-9.97%-4.71

-34.60%-4.75

-43.07%-5.02

1.24%-3.98

-13.04%-4.28

-0.24%-3.53

13.14%-3.51

---4.03

---3.79

---3.52

---4.04

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Celldex Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 CLDX 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Celldex Therapeutics Inc 財年末的營收是多少？



Celldex Therapeutics Inc 2025 財年營收為 1.54M，高於上一財年的 7.02M。

Celldex Therapeutics Inc 最近一個季度的營收是多少？



Celldex Therapeutics Inc 最近一個季度的營收為 22.00K，同比增長 -96.99%。

Celldex Therapeutics Inc 全年的淨利潤是多少？



Celldex Therapeutics Inc 2025 財年淨利潤為 -258.76M。

Celldex Therapeutics Inc 上一季度的淨利潤是多少？



Celldex Therapeutics Inc 最近一個季度的淨利潤為 -73.50M。

Celldex Therapeutics Inc 年度營業利潤是多少？



Celldex Therapeutics Inc 2025 財年的營業利潤為 -287.37M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。